30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Glenn Muir

Insider profile

Currently holds positions in Gen-Probe Inc, G1 Therapeutics Inc, Repligen Corp and Neuronetics Inc

Performance

Overall performance
3.9

Performance over holding periods
3.9
30 days 90 days 120 days
Average return 39% 8.2% 15.1%
Success rate 91% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Gen-Probe Inc Aug. 1, 2012 -
Independent Director G1 Therapeutics Inc Sept. 1, 2015 -
Independent Director Repligen Corp Sept. 15, 2015 -
Independent Director Neuronetics Inc July 1, 2017 -
Independent Director Lifeward Ltd July 1, 2014 - Dec. 29, 2017
Chief Financial Officer, Executive Vice President - Finance and Administration, Assistant Treasurer, Assistant Secretary Hologic Inc Aug. 5, 2013 - Nov. 30, 2014
Chief Financial Officer, Executive Vice President - Finance & Administration, Director Hologic Inc Jan. 1, 2008 - Aug. 5, 2013

Glenn Muir's trades of Neuronetics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-09-06 2024-09-05 B Purchase
74,031 -12.0%
326.81
US$1,916,814
74,031 -12.0% 326.81 US$1,916,814
2024-08-30 2024-08-29 B Purchase
78,343 +47.9%
398.67
US$2,165,543
78,343 +47.9% 398.67 US$2,165,543
2024-08-30 2024-08-28 B Purchase
93,071 +16.7%
257.80
US$2,853,629
93,071 +16.7% 257.80 US$2,853,629
2024-08-21 2024-08-20 B Purchase
25,000 +11.6%
1.00
US$25,000
25,000 +11.6% 1.00 US$25,000
2024-08-16 2024-08-14 B Purchase
25,171 +13.3%
0.75
US$18,878
25,171 +13.3% 0.75 US$18,878
2020-11-19 2020-11-18 B Purchase
50,000 +41.3%
13.50
US$675,000
50,000 +41.3% 13.50 US$675,000